+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inhalation Sevoflurane Anaesthetic Agent Market by End User (Ambulatory Surgery Centers, Clinics, Hospitals), Application (Cardiac Surgery, General Surgery, Neurological Surgery), Delivery Mode, Patient Age Group, Distribution Channel, Formulation - Global Forecast 2025-2030- Product Image
Inhalation Sevoflurane Anaesthetic Agent Market by End User (Ambulatory Surgery Centers, Clinics, Hospitals), Application (Cardiac Surgery, General Surgery, Neurological Surgery), Delivery Mode, Patient Age Group, Distribution Channel, Formulation - Global Forecast 2025-2030- Product Image
New

Inhalation Sevoflurane Anaesthetic Agent Market by End User (Ambulatory Surgery Centers, Clinics, Hospitals), Application (Cardiac Surgery, General Surgery, Neurological Surgery), Delivery Mode, Patient Age Group, Distribution Channel, Formulation - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6126389
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Sevoflurane has emerged as a cornerstone inhalational anaesthetic agent, recognized for its rapid induction and recovery profiles, minimal metabolism, and favorable hemodynamic stability. As healthcare providers seek to enhance patient outcomes and operational efficiency, this agent continues to gain prominence in both high-acuity surgical settings and outpatient procedures. Its physicochemical properties enable precise control of anaesthetic depth, while ongoing innovations in delivery systems promise to optimize administration and safety.

The purpose of this executive summary is to present a cohesive synthesis of the latest developments in clinical practice, regulatory shifts, segmentation dynamics, and regional trends surrounding sevoflurane. This overview draws from extensive qualitative interviews, peer-reviewed literature, and industry data to illuminate critical insights that will inform strategic decision-making, guide investment considerations, and support healthcare leaders in maximizing the benefits of this versatile inhalation anaesthetic agent.

Emerging Innovations and Clinical Advancements Reshaping the Sevoflurane Inhalation Anaesthetic Landscape Across Healthcare Settings Globally

The sevoflurane landscape has undergone transformative shifts driven by technological advancements and evolving clinical requirements. Recent innovations in vaporizer designs have enhanced dosing precision, while integration with digital monitoring platforms now offers real-time analytics on patient vitals and anaesthetic delivery. Concurrently, manufacturers are exploring environmentally sustainable formulations to address growing concerns about the global warming potential of halogenated ethers.

Moreover, regulatory bodies in major markets have introduced updated guidelines to streamline approval pathways for novel anaesthetic delivery devices and formulations, enabling expedited market entry for differentiated products. Across ambulatory care centers and high-volume hospitals alike, clinicians are adopting sevoflurane protocols tailored to specific surgical applications, reinforcing its versatility from cardiac and neurological interventions to pediatric and obstetric procedures.

Strategic Analysis of United States Tariffs Implemented in 2025 and Their Comprehensive Influence on Sevoflurane Supply Chains and Market Dynamics

In 2025, a new array of United States tariffs targeted key chemical precursors and specialized equipment integral to sevoflurane production and delivery. These measures have reverberated across international supply chains, prompting raw material suppliers to revisit sourcing strategies and manufacturers to assess alternative procurement options. As a result, procurement timelines have lengthened and transportation costs have escalated, compelling stakeholders to seek greater supply chain visibility and resilience.

Despite these challenges, industry participants have mitigated disruption through strategic inventory management, diversification of supplier networks, and collaborative negotiations with logistics providers. Looking ahead, continued dialogue between regulators, producers, and healthcare institutions will be essential to balance fiscal policy objectives with clinical imperatives, ensuring that sevoflurane remains accessible without compromising quality or affordability.

In-Depth Segmentation Framework Illuminating the Diverse Clinical, Delivery, and Distribution Channels Driving Sevoflurane Adoption Across Care Settings

An in-depth segmentation framework reveals the multifaceted drivers of sevoflurane adoption across a diverse array of care environments. Within the sphere of end users, ambulatory surgery centers-both hospital-affiliated and standalone-are capitalizing on rapid recovery times to expand same-day procedures, while clinics serving human and veterinary patients increasingly leverage sevoflurane’s stability to optimize throughput. Public and private hospitals continue to demand scalable solutions that address complex surgical workflows and stringent safety requirements.

Clinical applications span from cardiac and neurological surgery to obstetrics, pediatric, and general interventions, including abdominal, ENT, and orthopedic procedures. Meanwhile, delivery modes are evolving beyond traditional machine vaporizers to incorporate handheld and portable inhaler platforms that facilitate point-of-care flexibility. Distinct age segments-adult, geriatric, and pediatric-present unique pharmacokinetic considerations, driving tailored dosing regimens. Distribution pathways, whether through hospital pharmacies, online channels, or wholesale distributors, influence procurement lead times and cost structures. Across formulations, liquid concentrates, pre-valved cartridges, and ready-to-use solutions each offer different handling, storage, and preparation benefits.

Global Regional Dynamics and Comparative Advantages Shaping Sevoflurane Utilization and Accessibility Across Americas, Europe Middle East Africa, and Asia-Pacific

Regional analysis underscores significant variations in regulatory environments, infrastructure maturity, and clinical adoption rates. In the Americas, advanced healthcare systems and early adoption of digital anesthetic delivery solutions have cultivated robust sevoflurane utilization in both urban tertiary centers and outpatient facilities. Stakeholders in this region benefit from well-established supply networks and a supportive reimbursement landscape.

Within Europe, Middle East & Africa, regulatory harmonization efforts across the European Union have facilitated cross-border access to sevoflurane formulations, even as diverse national health systems present unique procurement and pricing challenges. Moreover, growth opportunities in emerging markets within the Middle East and Africa are driven by investments in surgical infrastructure and training programs that emphasize modern anesthetic protocols.

In Asia-Pacific, expanding surgical volumes, rising healthcare expenditure, and government initiatives to upgrade rural healthcare facilities are fueling demand. Market participants are establishing localized manufacturing and distribution partnerships to navigate complex import regulations, reduce lead times, and address price sensitivity in rapidly developing economies.

Competitive Landscape of Leading Pharmaceutical and Medical Device Companies Driving Innovation and Commercialization of Sevoflurane Anaesthetic Solutions

Major pharmaceutical and medical device companies are spearheading advancements in sevoflurane formulation and delivery technologies. Integrated manufacturers are investing in next-generation vaporizers that support automated dosing algorithms and improved environmental performance. Meanwhile, specialized anesthetic suppliers are forming strategic alliances to co-develop pre-filled cartridges and proprietary delivery systems, enhancing ease of use and reducing preparation errors.

A competitive landscape analysis highlights collaborations between established anesthesia equipment providers and contract manufacturing organizations, driven by a mutual objective to optimize production efficiency and ensure regulatory compliance. In parallel, emerging biotech firms are exploring novel carrier agents to refine pharmacokinetics and minimize systemic uptake. Across the value chain, these concerted efforts demonstrate a collective commitment to enhancing clinical outcomes and meeting the evolving needs of perioperative teams.

Practical Strategic Imperatives for Healthcare Stakeholders to Optimize Sevoflurane Deployment and Strengthen Market Position Through Innovation

Healthcare stakeholders should prioritize investments in comprehensive training programs that integrate the latest delivery devices with patient-monitoring technologies, ensuring consistent dosing accuracy and safety. Procurement teams must establish contingency plans with multiple qualified suppliers to mitigate potential supply disruptions stemming from policy changes or logistical constraints.

Moreover, organizations that adopt environmentally sustainable practices-such as low-flow anesthesia protocols and carbon offset initiatives-will not only reduce operational costs but also align with emerging regulatory standards. Cross-sector collaboration, including partnerships with veterinary practices and research institutions, can accelerate data sharing and foster innovation. By proactively engaging with regulatory authorities, clinical leaders can shape policies that balance patient safety with operational efficiency, securing long-term advantages in a competitive landscape.

Robust Multi-Method Research Approach Leveraging Qualitative and Quantitative Analyses to Ensure Rigorous Insights into Sevoflurane Market Trends

The research methodology underpinning these insights combines rigorous primary and secondary approaches. Expert interviews with anesthesiologists, procurement specialists, and regulatory officials provided qualitative perspectives on clinical adoption patterns and policy impacts. Comprehensive reviews of scientific journals, regulatory filings, and industry publications supplemented these findings with empirical data and historical context.

Quantitative analyses, including trend mapping and correlation studies, illuminated relationships between delivery technologies, procedural volumes, and patient demographics. A robust validation process involved cross-referencing proprietary survey results with public health statistics and peer-reviewed outcomes to ensure consistency. This multi-method framework guarantees that conclusions rest on a foundation of methodological integrity and triangulated evidence.

Summative Reflections on Sevoflurane’s Pivotal Role in Advancing Modern Surgical Anesthesia and Future Trajectories in Clinical Practice

Sevoflurane stands at the nexus of clinical efficacy, operational efficiency, and environmental stewardship within modern anesthetic practice. Its rapid induction and recovery characteristics have reshaped perioperative workflows, enabling greater procedural throughput and enhanced patient satisfaction. As delivery technologies and regulatory frameworks continue to evolve, sevoflurane’s adaptability positions it to address both current and emerging healthcare challenges.

Looking forward, sustained innovation in formulation and vaporizer design will be instrumental in maximizing therapeutic outcomes and minimizing ecological impact. Industry collaboration and proactive policy engagement will shape a future in which sevoflurane remains a reliable, cost-effective, and environmentally responsible choice for a broad spectrum of surgical applications. Ultimately, stakeholders who integrate these insights into strategic planning will secure enduring advantages in the dynamic field of inhalational anaesthesia.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • End User
    • Ambulatory Surgery Centers
      • Hospital Affiliated
      • Standalone
    • Clinics
      • Human Clinics
      • Veterinary Clinics
    • Hospitals
      • Private
      • Public
  • Application
    • Cardiac Surgery
    • General Surgery
      • Abdominal
      • Ent
      • Orthopedic
    • Neurological Surgery
    • Obstetrics And Gynecology
    • Pediatric Surgery
  • Delivery Mode
    • Handheld Vaporizer
    • Machine Vaporizer
    • Portable Inhaler
  • Patient Age Group
    • Adult
    • Geriatric
    • Pediatric
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Wholesale Distributors
  • Formulation
    • Liquid Concentrate
    • Pre Valved Cartridges
    • Ready To Use Solutions
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Baxter International Inc.
  • Abbott Laboratories
  • Piramal Pharma Limited
  • B. Braun Melsungen AG
  • Hikma Pharmaceuticals PLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in outpatient surgery centers driving demand for low blood solubility sevoflurane inhalation agent
5.2. Strategic collaborations between sevoflurane manufacturers and anesthesia device innovators to improve delivery efficiency
5.3. Growing emphasis on reducing greenhouse gas emissions from sevoflurane anesthetic use prompting eco friendly initiatives
5.4. Expansion of sevoflurane sales in Asia Pacific due to rising healthcare infrastructure investments in emerging markets
5.5. Competitive pricing pressure from generic sevoflurane entrants leading to margin optimization strategies among major suppliers
5.6. Advancements in vaporizer technology for precise sevoflurane dosing enhancing safety profiles in high risk surgeries
5.7. Regulatory approvals for new sevoflurane packaging formats improving dosing accuracy and reducing contamination risks
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Inhalation Sevoflurane Anaesthetic Agent Market, by End User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.2.1. Hospital Affiliated
8.2.2. Standalone
8.3. Clinics
8.3.1. Human Clinics
8.3.2. Veterinary Clinics
8.4. Hospitals
8.4.1. Private
8.4.2. Public
9. Inhalation Sevoflurane Anaesthetic Agent Market, by Application
9.1. Introduction
9.2. Cardiac Surgery
9.3. General Surgery
9.3.1. Abdominal
9.3.2. Ent
9.3.3. Orthopedic
9.4. Neurological Surgery
9.5. Obstetrics and Gynecology
9.6. Pediatric Surgery
10. Inhalation Sevoflurane Anaesthetic Agent Market, by Delivery Mode
10.1. Introduction
10.2. Handheld Vaporizer
10.3. Machine Vaporizer
10.4. Portable Inhaler
11. Inhalation Sevoflurane Anaesthetic Agent Market, by Patient Age Group
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Inhalation Sevoflurane Anaesthetic Agent Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Wholesale Distributors
13. Inhalation Sevoflurane Anaesthetic Agent Market, by Formulation
13.1. Introduction
13.2. Liquid Concentrate
13.3. Pre Valved Cartridges
13.4. Ready to Use Solutions
14. Americas Inhalation Sevoflurane Anaesthetic Agent Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Baxter International Inc.
17.3.2. Abbott Laboratories
17.3.3. Piramal Pharma Limited
17.3.4. B. Braun Melsungen AG
17.3.5. Hikma Pharmaceuticals PLC
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET: RESEARCHAI
FIGURE 28. INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET: RESEARCHSTATISTICS
FIGURE 29. INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET: RESEARCHCONTACTS
FIGURE 30. INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY STANDALONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HUMAN CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HUMAN CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ABDOMINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PEDIATRIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PEDIATRIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HANDHELD VAPORIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HANDHELD VAPORIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY MACHINE VAPORIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY MACHINE VAPORIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PORTABLE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PORTABLE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY LIQUID CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY LIQUID CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PRE VALVED CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PRE VALVED CARTRIDGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY READY TO USE SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY READY TO USE SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 134. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 135. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 142. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 143. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 144. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 145. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 170. MEXICO INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 256. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 257. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 264. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 265. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 267. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 268. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 269. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 272. GERMANY INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 273. FRANCE INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE INHALATION SEVOFLURANE ANAESTHETIC AGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE INHALATION SEVOFLURANE ANAESTHETIC AG

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Inhalation Sevoflurane Anaesthetic Agent market report include:
  • Baxter International Inc.
  • Abbott Laboratories
  • Piramal Pharma Limited
  • B. Braun Melsungen AG
  • Hikma Pharmaceuticals PLC

Related Topics

Related Reports

Inhalation Anaesthesia Market Report and Forecast 2024-2032 - Product Image

Inhalation Anaesthesia Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Inhalation Anesthesia Market Report 2025 - Product Image

Inhalation Anesthesia Market Report 2025

  • Report
  • 200 Pages
  • Global
From
South Korea General Anesthesia Market Report and Forecast 2024-2032 - Product Image

South Korea General Anesthesia Market Report and Forecast 2024-2032

  • Report
  • 138 Pages
  • South Korea
From
Inhalation Sevoflurane Anesthesia Drugs Market by Application (Ambulatory Anesthesia, General Anesthesia, Pediatric Anesthesia), End User (Ambulatory Surgical Centers, Clinics, Home Care Settings), Product Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Inhalation Sevoflurane Anesthesia Drugs Market by Application (Ambulatory Anesthesia, General Anesthesia, Pediatric Anesthesia), End User (Ambulatory Surgical Centers, Clinics, Home Care Settings), Product Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Sevoflurane for Inhalation Market by End User (Ambulatory Surgical Centers, Clinics, Hospitals), Product (Branded, Generic), Application, Distribution Channel - Global Forecast 2025-2030 - Product Image

Sevoflurane for Inhalation Market by End User (Ambulatory Surgical Centers, Clinics, Hospitals), Product (Branded, Generic), Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.